Yazar "Pittock, S." için listeleme

Toplam kayıt 4, listelenen: 1-4

Impact of Eculizumab on Hospitalization Rates and Relapse Treatment in Patients With AQP4+NMOSD: the Phase 3 PREVENT Study

Kim, H.; Pittock, S.; Berthele, A.; Fujihara, K.; Levy, M.; Palace, J.; Wingerchuk, D. (Sage Publications Ltd, 2020)

…
Impact of Eculizumab on Quality of Life in AQP4+NMOSD: Findings From the PREVENT Study

Berthele, A.; Pittock, S.; Fujihara, K.; Kim, H.; Levy, M.; Palace, J.; Wingerchuk, D. (Sage Publications Ltd, 2020)

…
Long-term Safety and Effectiveness of Eculizumab in Neuromyelitis Optica Spectrum Disorder

Wingerchuk, D.; Pittock, S.; Berthele, A.; Fujihara, K.; Kim, H.; Levy, M.; Armstrong, R. (Sage Publications Ltd, 2020)

…
Subgroup analyses from the Phase 3 PREVENT study in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder

Pittock, S.; Berthele, A.; Fujihara, K.; Kim, H. J.; Levy, M.; Palace, J.; Wingerchuk, D. M. (Sage Publications Ltd, 2019)

…